Get the Stockscreener App
1.80
1.10%
-0.02
Jaguar Health Inc stock is traded at $1.80, with a volume of 127.87K.
It is down -1.10% in the last 24 hours and down -25.00% over the past month.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
See More
Previous Close:
$1.82
Open:
$1.85
24h Volume:
127.87K
Relative Volume:
1.29
Market Cap:
$3.91M
Revenue:
$10.48M
Net Income/Loss:
$-37.74M
P/E Ratio:
-0.1112
EPS:
-16.1846
Net Cash Flow:
$-29.03M
1W Performance:
-14.29%
1M Performance:
-25.00%
6M Performance:
-91.59%
1Y Performance:
-94.15%
1-Day Range:
$1.78
$1.85
1-Week Range:
$1.78
$2.11
52-Week Range:
$1.78
$35.25
Jaguar Health Inc Stock (JAGX) Company Profile
Name
Jaguar Health Inc
Sector
Industry
Phone
415-371-8300
Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.80 | 3.96M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
Jaguar Health Inc Stock (JAGX) Latest News
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID) - The Florida Times-Union
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders - The Florida Times-Union
Jaguar Health Announces Promising Trial Results - TipRanks
27% TPN Reduction: Jaguar Health's Crofelemer Shows Promise in MVID Trial Ahead of FDA Strategy - Stock Titan
Jaguar Health Reports Increased Losses Amid Rising Expenses - MSN
Jaguar Health to meet with FDA on crofelemer for rare pediatric disease - Investing.com
27% Nutrition Requirement Reduction: Napo's Breakthrough Drug for Ultra-Rare Children's Disease Heads to FDA - Stock Titan
Trend analysis for Jaguar Health Inc. this weekWeekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
Will Jaguar Health Inc. stock recover after recent drop2025 Analyst Calls & Capital Protection Trading Alerts - Newser
RSI Suggests Rebound May Be Near in Jaguar Health Inc.Trade Risk Assessment & Real-Time Buy Zone Alerts - 선데이타임즈
Will breakout in Jaguar Health Inc. lead to full recoveryJuly 2025 Short Interest & Weekly Stock Performance Updates - Newser
Volume spikes in Jaguar Health Inc. stock – what they mean2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
Technical Models Detect Momentum Build in Jaguar Health Inc.2025 Biggest Moves & Free Safe Entry Trade Signal Reports - classian.co.kr
Jaguar Health : Supplement to Proxy Statement (a14554) - MarketScreener
Technical analysis overview for Jaguar Health Inc. stock2025 Top Gainers & Smart Swing Trading Techniques - Newser
Will earnings trigger a reversal in Jaguar Health Inc.July 2025 Outlook & Weekly Setup with High ROI Potential - Newser
Jaguar Health Inc. stock daily chart insightsBuy Signal & Technical Pattern Based Signals - Newser
Jaguar Health Posts Earnings Miss in Q2 2025, Market Reacts Cautiously - AInvest
Advanced analytics toolkit walkthrough for Jaguar Health Inc.Swing Trade & Safe Swing Trade Setups - Newser
Comparing Jaguar Health Inc. in custom built stock radarsJuly 2025 Pullbacks & Short-Term Swing Trade Alerts - Newser
Best data tools to analyze Jaguar Health Inc. stock2025 Short Interest & Free Growth Oriented Trading Recommendations - Newser
What momentum shifts mean for Jaguar Health Inc.2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
Intraday pattern recognizer results for Jaguar Health Inc.Trade Analysis Summary & Weekly Top Performers Watchlists - Newser
Key resistance and support levels for Jaguar Health Inc.2025 Major Catalysts & Growth Focused Entry Reports - Newser
What makes Jaguar Health Inc. stock price move sharplyWeekly Stock Summary & Community Consensus Stock Picks - Newser
Does Jaguar Health Inc. show high probability of reboundMarket Performance Recap & Real-Time Volume Trigger Notifications - Newser
How Jaguar Health Inc. stock performs during market volatilityM&A Rumor & Pattern Based Trade Signal System - Newser
What indicators show strength in Jaguar Health Inc.2025 Valuation Update & Fast Exit and Entry Trade Guides - Newser
Pattern recognition hints at Jaguar Health Inc. upsideJuly 2025 Weekly Recap & Weekly High Potential Alerts - Newser
Regression analysis insights on Jaguar Health Inc. performanceMarket Volume Report & High Win Rate Trade Tips - Newser
Heatmap Data Shows High Activity in Jaguar Health Inc. Sector2025 Market Overview & Technical Buy Zone Confirmations - beatles.ru
What risks could impact Jaguar Health Inc. stock performanceInflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Visualizing Jaguar Health Inc. stock with heatmapsJuly 2025 Pullbacks & Free Growth Oriented Trading Recommendations - Newser
Jaguar Health Inc. stock prediction for this weekInflation Watch & Smart Money Movement Alerts - Newser
Is Jaguar Health Inc. a play on infrastructure spendingEarnings Beat & Risk Adjusted Swing Trade Ideas - newsyoung.net
How to read the order book for Jaguar Health Inc.Weekly Gains Report & Risk Controlled Stock Pick Alerts - Newser
Published on: 2025-08-16 02:21:29 - Newser
Is Jaguar Health Inc. meeting your algorithmic filter criteria2025 Volume Leaders & Verified Momentum Stock Watchlist - Newser
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates - Canton Repository
What candlestick patterns are forming on Jaguar Health Inc.Portfolio Growth Summary & AI Driven Stock Reports - Newser
Jaguar Health Extends Market Offering Agreement - The Globe and Mail
Jaguar Health Inc (JAGX) Q2 2025 Earnings Call Highlights: Revenue Surge and Clinical Milestones Amid Financial Challenges - GuruFocus
Jaguar Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Jaguar Health Enters Sixth ATM Amendment with Ladenburg and Lucid: A Comprehensive Look at the Company's Focus on Gastrointestinal Health - AInvest
Jaguar Health enters sixth ATM amendment with Ladenburg and Lucid - MarketScreener
Jaguar Health extends Lucid Capital Markets role in ATM agreement to year-end - Investing.com
JAGX files Sixth ATM Amendment; Lucid retained through year-end - Stock Titan
Earnings call transcript: Jaguar Health Q2 2025 sees revenue boost, stock tumbles - Investing.com
Transcript : Jaguar Health, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
JAGX ATM amendment: Lucid extended; 1.37M shares sold for $22.9M - Stock Titan
Jaguar Health: Navigating Financial Turbulence Amid Orphan Drug Hopes - AInvest
Jaguar Health Inc Stock (JAGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):